Main News

12/18/2019

IVI appoints three new members to its Board of Trustees

December 18, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI), a Seoul, Korea-based international organization dedicated to accelerating vaccines for global health, announced today that Professor Gordon Dougan, Dr. Melanie Saville, and Dr. Jean-Marie Okwo-Bele will join its Board of Trustees (BOT) […]
01/09/2020

IVI to lead critical standard reagents availability for oral cholera vaccine manufacturing to ensure their uniform efficacy and help meet global demand

  January 9, 2020 – SEOUL, South Korea – The International Vaccine Institute (IVI) received a $1.4 million grant from the Bill & Melinda Gates Foundation to ensure critical standards and reagents are available to low-cost oral cholera vaccine (OCV) manufacturers in the global health […]
01/13/2020

IVI and Sweden renew partnership to accelerate vaccines for global public health

    January 13, 2020 – SEOUL, South Korea – The International Vaccine Institute (IVI), a Seoul, Korea-based international organization, announced today that the Swedish International Development Cooperation Agency (Sida) will continue to support IVI’s mission to accelerate vaccine research and development for global health […]
01/30/2020

How IVI is confronting schistosomiasis in Madagascar

As we globally recognize the first ever World Neglected Tropical Diseases Day, we take this opportunity to specifically raise awareness around Schistosomiasis, a devastating Neglected Tropical Disease (NTD) endemic in 78 low- and middle-income countries.   What is schistosomiasis? Schistosomiasis is a poverty-associated disease caused […]